Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025 This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Introduced
Jan 23, 2025
Last Action
Jan 23, 2025
Session
119th Congress
Sponsors
1 primary · 3 co
Passage Probability
2% — Very Low
Introduced in House
Referred to the House Committee on Energy and Commerce.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProReferred to the House Committee on Energy and Commerce.